Metformin to Reduce Heart Failure After Myocardial Infarction
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.
Also called NCT01217307
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 380 participants
- Sponsor
- Registry
-
NCT01217307
-
- Other papers using this trial's data
- Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction
- Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
- Effect of Metformin on Metabolites and Relation With Myocardial Infarct Size and Left Ventricular Ejection Fraction After Myocardial Infarction
- Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial
- Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01217307. Randomized; quadruple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2018-01-30.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin to Reduce Heart Failure After Myocardial Infarction
- Acronym
- GIPS-III
- Condition
- ST Elevation Myocardial Infarction (STEMI)
- Condition
- Coronary Artery Disease
- Condition
- Heart Failure
- Condition
- Diabetes
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Medical Center Groningen
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
Record details
- Record id
cardio:ct-nct01217307- Content hash
ca1b272150a6f2ac648fabd39712f61ddfab1121d5a7ca41e76033977d981fee